Antibiotic exposure for culture-negative early-onset sepsis in late-preterm and term newborns an international study /

Early-life antibiotic exposure is disproportionately high compared to the burden of culture-proven early-onset sepsis (CP-EOS). We assessed the contribution of culture-negative cases to the overall antibiotic exposure in the first postnatal week.We conducted a retrospective analysis across eleven co...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Dimopoulou Varvara
Klingenberg Claus
Navér Lars
Nordberg Viveka
Berardi Alberto
El Helou Salhab
Fusch Gerhard
Bliss Joseph M
Lehnick Dirk
Guerina Nicholas
Seliga-Siwecka Joanna
Maton Pierre
Lagae Donatienne
Mari Judit
Janota Jan
Agyeman Philipp K. A.
Pfister Riccardo
Latorre Giuseppe
Maffei Gianfranco
Laforgia Nicola
Mózes Enikő
Størdal Ketil
Strunk Tobias
Stocker Martin
Giannoni Eric
Kollaborációs szervezet: AENEAS Study Group
et al
Dokumentumtípus: Cikk
Megjelent: 2025
Sorozat:PEDIATRIC RESEARCH 97 No. 5
Tárgyszavak:
doi:10.1038/s41390-024-03532-6

mtmt:35349145
Online Access:http://publicatio.bibl.u-szeged.hu/35403
Leíró adatok
Tartalmi kivonat:Early-life antibiotic exposure is disproportionately high compared to the burden of culture-proven early-onset sepsis (CP-EOS). We assessed the contribution of culture-negative cases to the overall antibiotic exposure in the first postnatal week.We conducted a retrospective analysis across eleven countries in Europe, North America, and Australia. All late-preterm and term infants born between 2014 and 2018 who received intravenous antibiotics during the first postnatal week were classified as culture-negative cases treated for ≥5 days (CN ≥ 5d), culture-negative cases treated for <5 days (CN < 5d), or CP-EOS cases.Out of 757,979 infants, 21,703 (2.9%) received intravenous antibiotics. The number of infants classified as CN ≥ 5d, CN < 5d, and CP-EOS was 7996 (37%), 13,330 (61%), and 375 (1.7%). The incidence of CN ≥ 5d, CN < 5d, and CP-EOS was 10.6 (95% CI 10.3-10.8), 17.6 (95% CI 17.3-17.9), and 0.49 (95% CI 0.44-0.54) cases per 1000 livebirths. The median (IQR) number of antibiotic days administered for CN ≥ 5d, CN < 5d, and CP-EOS was 77 (77-78), 53 (52-53), and 5 (5-5) per 1000 livebirths.CN ≥ 5d substantially contributed to the overall antibiotic exposure, and was 21-fold more frequent than CP-EOS. Antimicrobial stewardship programs should focus on shortening antibiotic treatment for culture-negative cases.In a study of 757,979 infants born in high-income countries, we report a presumed culture-negative early-onset sepsis incidence of 10.6/1000 livebirths with an associated antibiotic exposure of 77 antibiotic days per 1000 livebirths. This study sheds light on the major contribution of presumed culture-negative early-onset sepsis to early-life antibiotic exposure. Given the diagnostic uncertainty surrounding culture-negative early-onset sepsis, the low mortality rate, and the disproportionate antibiotic exposure associated with this condition, our study emphasizes the importance of targeting culture-negative early-onset sepsis in antimicrobial stewardship programs.
Terjedelem/Fizikai jellemzők:1629-1635
ISSN:0031-3998